Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.

scientific article published in July 2003

Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1042/CS20020349
P698PubMed publication ID12589702
P5875ResearchGate publication ID10897250

P50authorMarit B. VeierødQ41664951
Paula BerstadQ59160807
P2093author name stringHarald Arnesen
Jan I Pedersen
Ingebjørg Seljeflot
Elsa M Hjerkinn
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectfatty acidQ61476
cell adhesionQ187640
fish oilQ1786125
P304page(s)13-20
P577publication date2003-07-01
P1433published inClinical ScienceQ372419
P1476titleSupplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
P478volume105

Reverse relations

cites work (P2860)
Q37230957Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Q36369055Changes in Oxidative Stress and Inflammatory Biomarkers in Fragile Adults over Fifty Years of Age and in Elderly People Exclusively Fed Enteral Nutrition
Q36064465Controlling inflammation: a fat chance?
Q34680900Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors
Q39696622Effects of EPA supplementation on plasma fatty acids composition in hypertriglyceridemic subjects with FABP2 and PPARα genotypes
Q50695043Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Q46947436Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects
Q24187985Effects of total fat intake on body weight
Q48181231Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.
Q52149532From alga to omega; have we reached peak (fish) oil?
Q37288199Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias
Q37376934Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.
Q35841798Nutrition and the endothelium
Q55919856Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q89958068Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q90307768Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q57689012Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Q93360900Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Q24197817Reduced or modified dietary fat for preventing cardiovascular disease
Q24235559Reduced or modified dietary fat for preventing cardiovascular disease
Q24187203Reduction in saturated fat intake for cardiovascular disease
Q34471990The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid
Q37670164Validity of a food frequency questionnaire to estimate long-chain polyunsaturated fatty acid intake among Japanese women in early and late pregnancy
Q36804819n-3 PUFA in CVD: influence of cytokine polymorphism

Search more.